Skip to content

Clinical trials

Observational Nervous System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Observational Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20141
20151
20161
20182
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Calgary2
BlueRock Therapeutics1
Duke University1
EMD Serono1
Innodem Neurosciences1
Massachusetts General Hospital1
Medtronic1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Shire1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases11
Brain Diseases3
Central Nervous System Diseases3
Autoimmune Diseases2
Cardiovascular Diseases2
Demyelinating Diseases2
Mental Disorders2
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1
Autoimmune Diseases of the Nervous System1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.